These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23503871)

  • 1. A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time.
    Tiselius HG
    Urolithiasis; 2013 Apr; 41(2):105-9. PubMed ID: 23503871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.
    Tiselius HG; Ferraz RR; Heilberg IP
    Urol Res; 2012 Aug; 40(4):285-91. PubMed ID: 22200737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
    Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
    BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composition of Urine Collected from Non-Stone-Forming Chinese Persons during Different Short-Term Periods of the Day.
    He Z; Chang Z; An L; Lei M; Jiang Z; Ou L; Wu W; Tiselius HG
    Urol Int; 2022; 106(3):227-234. PubMed ID: 33744905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of estimation of the urinary ion-activity products of calcium oxalate and calcium phosphate.
    Ogawa Y
    Hinyokika Kiyo; 1993 May; 39(5):407-11. PubMed ID: 8322621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approximate estimate of the ion-activity product of calcium oxalate in rat urine.
    Tiselius HG; Ferraz RR; Heilberg IP
    Urol Res; 2003 Dec; 31(6):410-3. PubMed ID: 14579106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
    Tiselius HG; Lindbäck B; Fornander AM; Nilsson MA
    Urol Res; 2009 Aug; 37(4):181-92. PubMed ID: 19444436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?
    Bek-Jensen H; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1996; 24(2):67-71. PubMed ID: 8740974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated urine analysis in patients with calcium stone disease.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1998; 33(3):323-32. PubMed ID: 9555561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
    Asplin JR; Bushinsky DA; Singharetnam W; Riordon D; Parks JH; Coe FL
    Kidney Int; 1997 Mar; 51(3):640-5. PubMed ID: 9067894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified estimate of the ion-activity product of calcium phosphate in urine.
    Tiselius HG
    Eur Urol; 1984; 10(3):191-5. PubMed ID: 6547093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythms of urinary saturation levels of calcium oxalate and calcium phosphate in normal male individuals.
    Ogawa Y
    Hinyokika Kiyo; 1993 Sep; 39(9):785-9. PubMed ID: 8213370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules.
    Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1999 Dec; 27(6):417-25. PubMed ID: 10651129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.